A case of adenocarcinoma of the rete testis with durable response to cisplatin-based chemotherapy.

adenocarcinoma of the rete testis cisplatin‐based chemotherapy

Journal

IJU case reports
ISSN: 2577-171X
Titre abrégé: IJU Case Rep
Pays: Australia
ID NLM: 101764958

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 22 10 2020
accepted: 14 04 2021
entrez: 9 9 2021
pubmed: 10 9 2021
medline: 10 9 2021
Statut: epublish

Résumé

Adenocarcinoma of the rete testis is a rare malignancy with a poor prognosis. We report a case of adenocarcinoma of the rete testis with a durable response to cisplatin-based chemotherapy. A 48-year-old man with Down syndrome (trisomy 21) presented with a 1-month history of painless swelling of the left scrotum. The physical examination revealed a left testis with a hydrocele associated with a tumor and enlarged pelvic and para-aortic lymph nodes. He underwent a radical orchiectomy. The specimen was diagnosed as adenocarcinoma of the rete testis. The patient received 7 cycles of chemotherapy (1 cycle of BEP and 6 cycles of EP) postoperatively. The metastatic lymph nodes were reduced in size for at least 12 months. Our patient with adenocarcinoma of the rete testis obtained an acceptable response to cisplatin-based chemotherapy. We treated a patient with an adenocarcinoma of the rete testis who had an acceptable response to platinum-based chemotherapy.

Identifiants

pubmed: 34497979
doi: 10.1002/iju5.12298
pii: IJU512298
pmc: PMC8413206
doi:

Types de publication

Case Reports

Langues

eng

Pagination

267-271

Informations de copyright

© 2021 The Authors. IJU Case Reports published by John Wiley & Sons Australia, Ltd on behalf of the Japanese Urological Association.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Urology. 1995 Oct;46(4):468-75
pubmed: 7571213
Mod Pathol. 2005 Feb;18 Suppl 2:S131-45
pubmed: 15502808
J Cutan Pathol. 2006 Feb;33(2):181-4
pubmed: 16420316
Int Cancer Conf J. 2017 Mar 1;6(2):84-87
pubmed: 31149477
Cancer Res. 1985 Oct;45(10):5145-50
pubmed: 4027990
Diagn Pathol. 2013 Jun 24;8:105
pubmed: 23800084
Urology. 1994 Oct;44(4):588-94
pubmed: 7941203
Urology. 2011 Feb;77(2):334
pubmed: 20451971
Int J Urol. 2006 Dec;13(12):1532-5
pubmed: 17118031
Nihon Hinyokika Gakkai Zasshi. 2010 Nov;101(7):749-53
pubmed: 21174741
Urol Case Rep. 2017 Nov 13;16:72-74
pubmed: 29226092
Am J Surg Pathol. 1984 Aug;8(8):625-34
pubmed: 6465420
Am J Surg Pathol. 2019 May;43(5):670-681
pubmed: 30676333
Korean J Urol. 2013 Jun;54(6):412-4
pubmed: 23789053
J Urol. 2000 Oct;164(4):1307-8
pubmed: 10992394

Auteurs

Shunsuke Owa (S)

Department of Nephro-Urologic Surgery and Andrology Mie University Hospital Tsu Mie Japan.

Takeshi Sasaki (T)

Department of Nephro-Urologic Surgery and Andrology Mie University Hospital Tsu Mie Japan.

Katsunori Uchida (K)

Department of Pathology Mie University Hospital Tsu Mie Japan.

Susumu Watanabe (S)

Department of Nephro-Urologic Surgery and Andrology Mie University Hospital Tsu Mie Japan.

Momoko Kato (M)

Department of Nephro-Urologic Surgery and Andrology Mie University Hospital Tsu Mie Japan.

Yusuke Sugino (Y)

Department of Nephro-Urologic Surgery and Andrology Mie University Hospital Tsu Mie Japan.

Manabu Kato (M)

Department of Nephro-Urologic Surgery and Andrology Mie University Hospital Tsu Mie Japan.

Satoru Masui (S)

Department of Nephro-Urologic Surgery and Andrology Mie University Hospital Tsu Mie Japan.

Kouhei Nishikawa (K)

Department of Nephro-Urologic Surgery and Andrology Mie University Hospital Tsu Mie Japan.

Yuko Yoshio (Y)

Department of Nephro-Urologic Surgery and Andrology Mie University Hospital Tsu Mie Japan.

Hideki Kanda (H)

Department of Nephro-Urologic Surgery and Andrology Mie University Hospital Tsu Mie Japan.

Yoshiki Sugimura (Y)

Department of Nephro-Urologic Surgery and Andrology Mie University Hospital Tsu Mie Japan.

Takahiro Inoue (T)

Department of Nephro-Urologic Surgery and Andrology Mie University Hospital Tsu Mie Japan.

Classifications MeSH